The Neuroinflammatory Response in Plaques and Amyloid Angiopathy in Alzheimers Disease: Therapeutic Implications
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
4
Page:
223-233
Author(s):
Annemieke J.M. Rozemuller, Willem A van Gool and Piet Eikelenboom
Editorial [Hot Topic: Pathophysiology and Current Therapeutics of Inflammatory Diseases (Guest Editor: Fadia R. Homaidan)]
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
4
Page:
281-281
Author(s):
Fadia R. Homaidan
Inflammation in Atherosclerosis: A New Therapeutic Target
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
4
Page:
283-295
Author(s):
H. N. Skouri, P. A. Zalloua and A. B. Abchee
Biologic and Novel Therapy of the Inflammatory Bowel Diseases
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
4
Page:
319-331
Author(s):
Frederick L. Makrauer and Robert Burakoff
Update on the Therapy of Behçets Disease
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
4
Page:
339-348
Author(s):
T. Arayssi and A. Hamdan
Prostaglandins and Cyclooxygenases in Glial Cells During Brain Inflammation
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
4
Page:
335-340
Author(s):
Shun-Fen Tzeng, Han-Yun Hsiao and Oi-Tong Mak
Development of COX-2 Selective Inhibitors - Therapeutic Perspectives
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
5
Page:
241-248
Author(s):
S. R. Casturi, P. Hegde and R. Ramanujam
The Endocrine Function of Adipose Tissue
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
5
Page:
293-296
Author(s):
Tiziana Ronti, Graziana Lupattelli and Elmo Mannarino
Inhibitors of Cyclin-Dependent Kinases: Potential Drugs for the Treatment of Neurodegenerative Disorders?
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
5
Page:
101-109
Author(s):
Merce Pallas, Anna M. Canudas, Ester Verdaguer, Clemens Allgaier, Susana Garcia de Arriba, Daniel Alvira, Francesc X. Sureda and Antoni Camins
CD14-Dependent Innate Immunity-Mediated Neuronal Damage in Vivo is Suppressed by NSAIDs and Ablation of a Prostaglandin E2 Receptor, EP2
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
5
Page:
151-156
Author(s):
D. Milatovic, S. Zaja-Milatovic, K. S. Montine, M. Nivison and T. J. Montine